Karnataka: Shilpa Medicare has received the Good Manufacturing Practice (GMP) Certification after the successful closure of ...

Frontline tyrosine kinase inhibitors are well-established for chronic myelogenous leukemia, but some patients experience inadequate response or adverse events, highlighting the need for novel ...

The FDA has granted approval for the use of encorafenib in combination with cetuximab and mFOLFOX6 for the treatment of ...

Dr. Ruemu Birhiray explains chronic myeloid leukemia (CML), its treatment options, and what patients should know about this ...

As criticism of pharmacy benefit managers heats up, fear of lawsuits is driving some big employers to drop the “Big Three” ...

FDA gives nod of approval to first derived mesenchymal stromal cell therapy for the treatment of pediatric patients with ...

In the hopes of helping the greater good, George joined MRA’s RARE Registry, a registry for patients with acral, mucosal, and ...

Ruxolitinib for treating acute graft versus host disease refractory to corticosteroids in people aged 12 and over [ID6377] Draft guidance Technology appraisal guidance 10 January 2025 Cladribine for ...

Charles Schwab Investment Management Inc. lowered its stake in shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Free ...

After hours: December 19 at 5:15:15 PM EST Loading Chart for TENX ...

在市场信心的显著表现下，Inhibikase Therapeutics ...

The basis of peptide vaccination is the observation that leukemia cells can act as antigen-presenting cells (APCs) that cleave endogenous leukemia antigens in their proteasome and present them on ...